Vaxart, Inc.·4

May 26, 5:11 PM ET

Watson W. Mark 4

4 · Vaxart, Inc. · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Vaxart (VXRT) Director Watson W. Mark Buys 10,000 Shares

What Happened
Watson W. Mark, a director of Vaxart, Inc. (VXRT), purchased 10,000 shares in an open-market transaction on May 22, 2026. The shares were bought at $0.65 per share for a reported total of $6,530. This was a purchase (transaction code P), which investors often view as a more informative signal than routine sales.

Key Details

  • Transaction date: 2026-05-22; Price: $0.65 per share; Total reported value: $6,530.
  • Transaction type: Open-market purchase (Code P).
  • Shares owned following the transaction: Not specified in the provided report.
  • Footnotes/Plans: No 10b5-1 plan, tax withholding, or other footnotes were noted in the supplied summary.
  • Filing/timeliness: Form 4 filed with the SEC on 2026-05-26; based on the two-business-day rule (May 25 was a holiday), this filing appears timely.

Context
Insider purchases can signal confidence but the dollar amount here is modest (~$6.5K), so it may reflect a routine purchase rather than a material bet on the company. Retail investors should consider this alongside other insider activity, company updates, and broader market factors before drawing conclusions.

Insider Transaction Report

Form 4
Period: 2026-05-22
Transactions
  • Purchase

    Common Stock

    2026-05-22$0.65/sh+10,000$6,530134,125 total
Signature
/s/ Edward Berg, Attorney-in-Fact for W. Mark Watson|2026-05-26

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4